Clinical Trial Update: Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria [NA]

View source ↗

Summary

The document notes a completed clinical trial studying cysteine hydrochloride for erythropoietic protoporphyria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria

Drugs mentioned

• Cysteine Hydrochloride (Cysteine Hydrochloride)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Erythropoietic Protoporphyria | NA | Status: COMPLETED